ストックスクリーナーアプリを入手
2.90
1.02%
-0.03
アフターアワーズ：
2.90
前日終値:
$2.93
開ける：
$2.93
24時間の取引高:
1.44M
Relative Volume:
2.71
時価総額：
$183.42M
収益：
-
当期純損益:
$-69.31M
株価収益率:
-2.2835
EPS:
-1.27
ネットキャッシュフロー:
$-62.80M
1週間 パフォーマンス:
-4.29%
1か月 パフォーマンス:
-34.54%
6か月 パフォーマンス:
-40.21%
1年 パフォーマンス:
+13.73%
1日の値動き範囲:
$2.73
$2.98
1週間の範囲:
$2.69
$3.1365
52週間の値動き範囲:
$2.22
$6.1856
Rezolute Inc Stock (RZLT) Company Profile
名前
Rezolute Inc
セクター
電話
650-206-4507
住所
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
RZLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
2.90 | 183.42M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | Wedbush | Outperform |
| 2024-08-27 | 開始されました | Guggenheim | Buy |
| 2024-07-17 | 開始されました | BTIG Research | Buy |
| 2024-06-04 | 開始されました | Craig Hallum | Buy |
| 2024-04-09 | 開始されました | Maxim Group | Buy |
| 2022-08-02 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-09-08 | 開始されました | ROTH Capital | Buy |
| 2021-05-27 | 開始されました | Oppenheimer | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Rezolute Inc (RZLT) 最新ニュース
rezolute CEO Elam Nevan buys $34,999 in common shares By Investing.com - Investing.com Australia
rezolute CEO Elam Nevan buys $34,999 in common shares - Investing.com
Rezolute’s CFO Makes Bold Move with Major Stock Purchase! - TipRanks
Rezolute Appoints Erik Harris to Board of Directors - TipRanks
Rezolute CFO Daron Evans acquires $57,700 in common shares - Investing.com India
Rezolute Inc (NASDAQ: RZLT): Getting A Free Pass? - Stocks Register
Rezolute expands board with biopharma veteran Erik Harris By Investing.com - Investing.com South Africa
Rezolute expands board with biopharma veteran Erik Harris - Investing.com
Rezolute Announces Appointment of Rare Disease Commercial Leader Erik Harris to its Board of Directors - The Manila Times
Strategic Move: Ultragenyx CCO Erik Harris to Drive Rezolute's Rare Disease Commercialization - Stock Titan
Comparing Rezolute (NASDAQ:RZLT) & Akero Therapeutics (NASDAQ:AKRO) - Defense World
Here's Why Rezolute (RZLT) Looks Ripe for Bottom Fishing - Nasdaq
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) Price Target at $24.38 - Defense World
JMP Securities lifts Rezolute stock target to $9, maintains rating - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Rating of "Buy" from Analysts - MarketBeat
A Guide To The Risks Of Investing In Rezolute Inc (RZLT) - Knox Daily
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus.com
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares By Investing.com - Investing.com Nigeria
Rezolute director Wladimir Hogenhuis purchases $47,000 in common shares - Investing.com India
Hedge Fund and Insider Trading News: Scott Bessent, Warren Buffett, Stanley Druckenmiller, Tybourne Capital Management, Millennium Management, Rezolute Inc (RZLT), Rambus Inc (RMBS), and More - Insider Monkey
Insider Trading Highlights: Wednesday's Key Moves in US Stocks - Investing.com
Short Interest in Rezolute, Inc. (NASDAQ:RZLT) Rises By 17.4% - MarketBeat
Rezolute director Kim Young-Jin buys $5 million in shares By Investing.com - Investing.com Australia
Rezolute director Kim Young-Jin buys $5 million in shares - Investing.com
Rezolute's SWOT analysis: biotech stock advances on ersodetug trials - MSN
Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - MarketBeat
JMP Securities Issues Positive Forecast for Rezolute (NASDAQ:RZLT) Stock Price - MarketBeat
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT) - Seeking Alpha
Rezolute’s SWOT analysis: biotech stock advances on ersodetug trials By Investing.com - Investing.com Nigeria
What is Wedbush’s Estimate for Rezolute FY2029 Earnings? - Defense World
What is Wedbush's Estimate for Rezolute FY2029 Earnings? - MarketBeat
What is HC Wainwright’s Estimate for Rezolute Q1 Earnings? - Defense World
Rezolute (NASDAQ:RZLT) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
Rezolute’s Strategic Advances in Rare Disease Therapies - MSN
Guggenheim Reiterates Buy Rating for Rezolute (NASDAQ:RZLT) - MarketBeat
JMP Securities lifts Rezolute stock target to $9, maintains rating By Investing.com - Investing.com Australia
Rezolute Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Rezolute Inc. (RZLT) reports earnings - Quartz
Rezolute Inc (RZLT) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):